Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.
Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.
复制标题
DOI:
10.1007/s00262-011-1130-3
复制
发表时间:
2012-05
影响因子:
5.8
通讯作者:
Parajuli, Prahlad
中科院分区:
文献类型:
--
作者:
Dandawate, Sagar;Williams, Linford;Joshee, Nirmal;Rimando, Agnes M.;Mittal, Sandeep;Thakur, Archana;Lum, Lawrence G.;Parajuli, Prahlad
A number of studies have implicated tumor-induced Treg cell activity in the sub-optimal response to therapeutic vaccines. Development of neo-adjuvant strategies targeting Treg cells is therefore imperative. Scutellaria extracts or constituent flavonoids have shown encouraging efficacy against various tumors, including gliomas, in both pre-clinical and clinical studies. We report here, for the first time, that Scutellaria ocmulgee leaf extract (SocL) and flavonoid wogonin could inhibit TGF-β1-induced Treg activity in malignant gliomas. F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-β1 and Treg cell frequency as well as peripheral blood TGF-β1 levels in SocL-treated animals compared to the controls. SocL extract and wogonin also inhibited glioma-induced, TGF-β1-mediated Treg activity in vitro. SocL extract and wogonin also inhibited the secretion of IL-10 in Treg culture; whereas the level of IL-2 was either unchanged or marginally enhanced. We also observed an inhibition of Smad-3, GSK-3β and ERK1/2 signaling by SocL and wogonin in Treg cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells’ response to TGF-β1 via modulation of both Smad and non-Smad signaling pathways. Overall, this study suggests that Scutellaria can potentially reverse tumor-mediated immune suppression via inhibition of TGF-β1 secretion as well as via inhibition of T cells’ response to TGF-β1. This may provide an opportunity for developing a novel adjuvant therapeutic strategy for malignant gliomas, combining Scutellaria with immunotherapy and chemo/radio-therapeutic regimen, which could potentially improve the disease outcome.
登录
查看更多内容
DOI:
10.4049/jimmunol.0804074
发表时间:
2009-05-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Jacob JB;Kong YC;Nalbantoglu I;Snower DP;Wei WZ
通讯作者:
Wei WZ
影响因子:
14.8
作者:
Fantini, Massimo C.;Dominitzki, Sabine;Becker, Christoph
通讯作者:
Becker, Christoph
影响因子:
11.2
作者:
Bergmann, Christoph;Strauss, Laura;Whiteside, Theresa L.
通讯作者:
Whiteside, Theresa L.
影响因子:
3.4
作者:
Burdette-Radoux, S;Tozer, RG;Eisenhauer, EA
通讯作者:
Eisenhauer, EA
影响因子:
11.2
作者:
Domschke, Christoph;Schuetz, Florian;Beckhove, Philipp
通讯作者:
Beckhove, Philipp